Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Systemic GLP-1R agonist treatment reverses mouse glial and neurovascular cell transcriptomic aging signatures in a genome-wide manner

Open access

Abstract

Pharmacological reversal of brain aging is a long-sought yet challenging strategy for the prevention and treatment of age-related neurodegeneration, due to the diverse cell types and complex cellular pathways impacted by the aging process. Here, we report the genome-wide reversal of transcriptomic aging signatures in multiple major brain cell types, including glial and mural cells, by systemic glucagon-like peptide-1 receptor (GLP-1R) agonist (GLP-1RA) treatment. The age-related expression changes reversed by GLP-1RA encompass both shared and cell type-specific functional pathways that are implicated in aging and neurodegeneration. Concomitantly, Alzheimer’s disease (AD)-associated transcriptomic signature in microglia that arises from aging is reduced. These results show the feasibility of reversing brain aging by pharmacological means, provide mechanistic insights into the neurological benefits of GLP-1RAs, and imply that GLP-1R agonism may be a generally applicable pharmacological intervention for patients at risk of age-related neurodegeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-021-02208-9

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Reversal of glial and neurovascular cell transcriptomic aging signatures by GLP-1RA treatment. a UMAP visualization of the major cell type clusters identified and analysed. Numbers in brackets: cell numbers for the respective cell types. AC astrocyte, OPC oligodendrocyte precursor cell, MG microglia, MAC perivascular macrophage, OLG oligodendrocyte, SMC smooth muscle cell, PC pericyte, EC endothelial cell. b UMAP visualization of the single-cell transcriptomes from young adult, aged, and GLP-1RA (exenatide)-treated aged mouse brains. For each plot, colored dots highlight cells from the respective labeled group, while gray dots are cells from the other groups. Numbers in brackets: cell numbers for the respective groups in the dataset (n = 3 animals for each group). For clarity, 6000 cells were subsampled for visualization in each plot in a and b. c Age-related expression changes (x-axis) plotted against post-exenatide treatment expression changes (y-axis) in glial (AC, OPC, MG, and OLG), vascular (EC, PC, and SMC) cell types, and MAC. Each dot represents one differentially expressed gene (DEG). lnFC: natural log of fold change. Gray lines: lines of best fit by linear regression. d Proportions of DEGs reversed and the slopes of lines of best fit by linear regression shown in c in the different cell types. See Supplementary Data 1 for source data underlying (c).
Fig. 1 Reversal of glial and neurovascular cell transcriptomic aging signatures by GLP-1RA treatment. a UMAP visualization of the major cell type clusters identified and analysed. Numbers in brackets: cell numbers for the respective cell types. AC astrocyte, OPC oligodendrocyte precursor cell, MG microglia, MAC perivascular macrophage, OLG oligodendrocyte, SMC smooth muscle cell, PC pericyte, EC endothelial cell. b UMAP visualization of the single-cell transcriptomes from young adult, aged, and GLP-1RA (exenatide)-treated aged mouse brains. For each plot, colored dots highlight cells from the respective labeled group, while gray dots are cells from the other groups. Numbers in brackets: cell numbers for the respective groups in the dataset (n = 3 animals for each group). For clarity, 6000 cells were subsampled for visualization in each plot in a and b. c Age-related expression changes (x-axis) plotted against post-exenatide treatment expression changes (y-axis) in glial (AC, OPC, MG, and OLG), vascular (EC, PC, and SMC) cell types, and MAC. Each dot represents one differentially expressed gene (DEG). lnFC: natural log of fold change. Gray lines: lines of best fit by linear regression. d Proportions of DEGs reversed and the slopes of lines of best fit by linear regression shown in c in the different cell types. See Supplementary Data 1 for source data underlying (c).CC BY · PubMed Central
Fig. 2 Functional pathway analysis of the GLP-1RA treatment-reversed age-related transcriptomic changes. a Pathways with significant enrichment among the most prominent age-related expression changes reversed by exenatide treatment in the different cell types. b Dot plots of expression changes of selected functionally important genes in AC, MG, and SMC, in aging and post-exenatide treatment. c UMAP visualization and d violin plots of AD signature scores in the MGs from young adult, aged and exenatide-treated aged mouse brains. Numbers in brackets in c: cell numbers for the respective groups in the dataset. Horizontal lines in d represent medians (young adult, 0.36; aged, 0.46; exenatide-treated aged: 0.43), 25th and 75th percentiles. Comparison of Alzheimer’s disease (AD) signature scores in the MGs among the three groups: P = 2.2 × 10−16, Kruskal–Wallis test; the P-values of pairwise comparisons by post hoc Dunn’s test are shown in d. Cell type abbreviations: same as in Fig. 1. See Supplementary Data 1 for source data underlying a and b.
Fig. 2 Functional pathway analysis of the GLP-1RA treatment-reversed age-related transcriptomic changes. a Pathways with significant enrichment among the most prominent age-related expression changes reversed by exenatide treatment in the different cell types. b Dot plots of expression changes of selected functionally important genes in AC, MG, and SMC, in aging and post-exenatide treatment. c UMAP visualization and d violin plots of AD signature scores in the MGs from young adult, aged and exenatide-treated aged mouse brains. Numbers in brackets in c: cell numbers for the respective groups in the dataset. Horizontal lines in d represent medians (young adult, 0.36; aged, 0.46; exenatide-treated aged: 0.43), 25th and 75th percentiles. Comparison of Alzheimer’s disease (AD) signature scores in the MGs among the three groups: P = 2.2 × 10−16, Kruskal–Wallis test; the P-values of pairwise comparisons by post hoc Dunn’s test are shown in d. Cell type abbreviations: same as in Fig. 1. See Supplementary Data 1 for source data underlying a and b.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 42

Metadata

Authors
Li, Z., Chen, X., Vong, J. S. L., Zhao, L., Huang, J., Yan, L. Y. C., Ip, B., Wing, Y. K., Lai, H.-M., Mok, V. C. T., & Ko, H.
Affiliations
Chinese University of Hong Kong (HK)
Corresponding author
  • Mok, Vincent C. T.
  • Ko, Ho
Venue
Communications Biology
Published
2021-06-02
Volume
4
Issue
1
Pages
656-656
ISSN
2399-3642 (ISSN-L)
OpenAlex
W3164467445
Cited by
42
References
37
Citations by year
2026: 8 · 2025: 16 · 2024: 11 · 2023: 5 · 2022: 2
FWCI
1.61
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Croucher Foundation (CIA20CU01)
  • University Grants Committee (AoE/M-604/16)
  • Chinese University of Hong Kong (FIA2017/B/01, FIA2020/B/01)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
GLP-1 receptor agonists, brain aging, age-related neurodegeneration, microglia, glial cells, mural cells, Alzheimer's disease, cell type-specific gene expression
MeSH terms
Glucagon-Like Peptide-1 Receptor, Exenatide, Glucagon-Like Peptide-1 Receptor Agonists, Aging, Alzheimer Disease, Animals, Brain, Feasibility Studies, Humans, Male, Mice, Inbred C57BL, Neuroglia, Cellular Senescence, Neurodegenerative Diseases, Mice, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systemic GLP-1R agonist treatment reverses mouse glial and neurovascular cell transcriptomic aging signatures in a genome-wide manner. https://app.cochat.ai/papers/10.1038/s42003-021-02208-9
The paper
Li, Z., Chen, X., Vong, J. S. L., Zhao, L., Huang, J., Yan, L. Y. C., Ip, B., Wing, Y. K., Lai, H.-M., Mok, V. C. T., & Ko, H. (2021). Systemic GLP-1R agonist treatment reverses mouse glial and neurovascular cell transcriptomic aging signatures in a genome-wide manner. Communications Biology. https://doi.org/10.1038/s42003-021-02208-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.